Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases?

Simon Spedding, Simon Vanlint, Howard Morris, Robert Scragg, Simon Spedding, Simon Vanlint, Howard Morris, Robert Scragg

Abstract

Objective: Clarify the concept of vitamin D sufficiency, the relationship between efficacy and vitamin D status and the role of Vitamin D supplementation in the management of non-skeletal diseases. We outline reasons for anticipating different serum vitamin D levels are required for different diseases.

Method: Review the literature for evidence of efficacy of supplementation and minimum effective 25-hydroxyvitamin D (25-OHD) levels in non-skeletal disease.

Results: Evidence of efficacy of vitamin supplementation is graded according to levels of evidence. Minimum effective serum 25-OHD levels are lower for skeletal disease, e.g., rickets (25 nmol/L), osteoporosis and fractures (50 nmol/L), than for premature mortality (75 nmol/L) or non-skeletal diseases, e.g., depression (75 nmol/L), diabetes and cardiovascular disease (80 nmol/L), falls and respiratory infections (95 nmol/L) and cancer (100 nmol/L).

Conclusions: Evidence for the efficacy of vitamin D supplementation at serum 25-OHD levels ranging from 25 to 100 nmol/L has been obtained from trials with vitamin D interventions that change vitamin D status by increasing serum 25-OHD to a level consistent with sufficiency for that disease. This evidence supports the hypothesis that just as vitamin D metabolism is tissue dependent, so the serum levels of 25-OHD signifying deficiency or sufficiency are disease dependent.

References

    1. Ross A., Taylor C., Yaktine A., del Valle H. The National Academies Press; Washington, DC, USA: 2010. Dietary reference intakes for calcium and vitamin D.
    1. Morris H., Anderson P. Autocrine and paracrine actions of vitamin D. Clin. Biochem. Rev. 2010;31:129–138.
    1. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., Handunnetthi L., Handel A.E., Disanto G., Orton S.-M., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res. 2010;20:1352–1360. doi: 10.1101/gr.107920.110.
    1. Holick M. The vitamin D deficiency pandemic: A forgotten hormone important for health. Pubic Health Rev. 2010;32:267–283.
    1. Daly R.M., Gagnon C., Lu Z.X., Magliano D.J., Dunstan D.W., Sikaris K.A., Zimmet P.Z., Ebeling P.R., Shaw J.E. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: A national, population-based study. Clin. Endocrinol. 2012;77:26–35. doi: 10.1111/j.1365-2265.2011.04320.x.
    1. Van der Mei I., Ponsonby A., Engelsen O., Pasco J., McGrath J., Eyles D., Blizzard L., Dwyer T., Lucas R., Jones G. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ. Health Perspect. 2007;115:1132–1139. doi: 10.1289/ehp.9937.
    1. Sud S.R., Montenegro-Bethancourt G., Bermúdez O.I., Heaney R.P., Armas L., Solomons N.W. Older Mayan residents of the western highlands of Guatemala lack sufficient levels of vitamin D. Nutr. Res. 2010;30:739–746. doi: 10.1016/j.nutres.2010.10.003.
    1. Sheikh A., Saeed Z., Jafri S.A.D., Yazdani I., Hussain S.A. Vitamin D levels in asymptomatic adults—A population survey in Karachi, Pakistan. PLoS One. 2012;7:e33452.
    1. Arabi A., El Rassi R., El-Hajj Fuleihan G. Hypovitaminosis D in developing countries—Prevalence, risk factors and outcomes. Nat. Rev. Endocrinol. 2010;6:550–561. doi: 10.1038/nrendo.2010.146.
    1. Lips P. Worldwide status of vitamin D nutrition. J. Steroid Biochem. Mol. Biol. 2010;121:297–300. doi: 10.1016/j.jsbmb.2010.02.021.
    1. Scragg R. Vitamin D and public health: An overview of recent research on common diseases and mortality in adulthood. Pubic Health Nutr. 2011;14:1515–1532. doi: 10.1017/S1368980011001455.
    1. Exponential Growth in Vitamin D Publications. [(accessed on 2 November 2013)]. Available online: .
    1. Heaney R. Vitamin D—Baseline status and effective dose. N. Engl. J. Med. 2012;367:77–78. doi: 10.1056/NEJMe1206858.
    1. Heaney R. Nutrients, endpoints, and the problem of proof. J. Nutr. 2008;138:1591–1595.
    1. Lappe J., Heaney R. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermato-Endocrinology. 2012;4:95–100. doi: 10.4161/derm.19833.
    1. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., Bassford T., Beresford S.A.A., Black H.R., Blanchette P., et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006;354:669–683. doi: 10.1056/NEJMoa055218.
    1. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O’Sullivan M.J., Margolis K.L., Ockene J.K., Phillips L., Pottern L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006;354:684–696. doi: 10.1056/NEJMoa055222.
    1. Dean A., Bellgrove M., Hall T., Phan W., Eyles D., Kvaskoff D., McGrath J. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults—A randomised controlled trial. PLoS One. 2011;61:e25966.
    1. Jorde R., Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur. J. Nutr. 2009;48:349–354. doi: 10.1007/s00394-009-0020-3.
    1. Hendrix I., Anderson P., May B., Morris H. Regulation of gene expression by the CYP27B1 promoter—Study of a transgenic mouse model. J. Steroid Biochem. Mol. Biol. 2004;89–90:139–142.
    1. Turner A.G., Anderson P.H., Morris H.A. Vitamin D and bone health. Scand. J. Clin. Lab. Investig. 2012;72:65–72.
    1. NHMRC Additional Levels of Evidence and Grades for Recommendations for Developers of Guidelines. [(accessed on 2 November 2013)]. Available online: .
    1. Bjelakovic G., Gluud Lise L., Nikolova D., Whitfield K., Wetterslev J., Simonetti Rosa G., Bjelakovic M., Gluud C. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd.; New York, NY, USA: 2011. Vitamin D Supplementation for Prevention of Mortality in Adults.
    1. Ford E.S., Zhao G., Tsai J., Li C. Vitamin D and all-cause mortality among adults in USA: Findings from the national health and nutrition examination survey linked mortality study. Int. J. Epidemiol. 2011;40:998–1005. doi: 10.1093/ije/dyq264.
    1. Schöttker B., Haug U., Schomburg L., Köhrle J., Perna L., Müller H., Holleczek B., Brenner H. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am. J. Clin. Nutr. 2013;97:782–793. doi: 10.3945/ajcn.112.047712.
    1. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am. J. Clin. Nutr. 2007;85:1586–1591.
    1. Garland C., Gorham E.D., Mohr S.B., Garland F.C. Vitamin D for cancer prevention: Global perspective. Ann. Epidemiol. 2009;19:468–483. doi: 10.1016/j.annepidem.2009.03.021.
    1. Grant W.B. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J. Photochem. Photobiol. 2010;101:130–136. doi: 10.1016/j.jphotobiol.2010.04.008.
    1. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., Wong J.B., Egli A., Kiel D.P., Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. doi: 10.1136/bmj.b3692.
    1. Cranney A., Weiler H.A., O’Donnell S., Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am. J. Clin. Nutr. 2008;88:513S–519S.
    1. Gillespie L., Robertson M., Gillespie W. Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 2009 doi: 10.1002/14651858.CD007146.pub2.
    1. Murad M.H., Elamin K.B., Abu Elnour N.O., Elamin M.B., Alkatib A.A., Fatourechi M.M., Almandoz J.P., Mullan R.J., Lane M.A., Liu H., et al. The effect of vitamin D on falls: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011;96:2997–3006. doi: 10.1210/jc.2011-1193.
    1. Scragg R. Do we need to take calcium with vitamin D supplements to prevent falls, fractures, and death? Curr. Opin. Clin. Nutr. Metab. Care. 2012;15:614–624. doi: 10.1097/MCO.0b013e328359ef21.
    1. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F., Zhang Y., Karlson E., Dawson-Hughes B. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am. J. Clin. Nutr. 2004;80:752–758.
    1. Stockton K., Mengersen K., Paratz J., Kandiah D., Bennell K. Effect of vitamin D supplementation on muscle strength: A systematic review and meta-analysis. Osteoporos. Int. 2011;22:859–871.
    1. Grandi N.C., Breitling L.P., Brenner H. Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Prev. Med. 2010;51:228–233. doi: 10.1016/j.ypmed.2010.06.013.
    1. Sokol S.I., Tsang P., Aggarwal V., Melamed M.L., Srinivas V.S. Vitamin D status and risk of cardiovascular events: Lessons learned via systematic review and meta-analysis. Cardiol. Rev. 2011;19:192–201. doi: 10.1097/CRD.0b013e31821da9a5.
    1. Brøndum-Jacobsen P., Benn M., Jensen G.B., Nordestgaard B.G. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death. Arterioscler. Thromb. Vasc. Biol. 2012;32:2794–2802. doi: 10.1161/ATVBAHA.112.248039.
    1. Vacek J.L., Vanga S.R., Good M., Lai S.M., Lakkireddy D., Howard P.A. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am. J. Cardiol. 2012;109:359–363. doi: 10.1016/j.amjcard.2011.09.020.
    1. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.-B., Clarke A., Franco O.H. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas. 2010;65:225–236. doi: 10.1016/j.maturitas.2009.12.013.
    1. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 2009;57:1595–1603. doi: 10.1111/j.1532-5415.2009.02359.x.
    1. Manaseki-Holland S., Qader G., Isaq Masher M., Bruce J., Zulf Mughal M., Chandramohan D., Walraven G. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: A randomised controlled trial. Trop. Med. Int. Health. 2010;15:1148–1155. doi: 10.1111/j.1365-3156.2010.02578.x.
    1. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010;91:1255–1260. doi: 10.3945/ajcn.2009.29094.
    1. Camargo C.A., Ganmaa D., Frazier A.L., Kirchberg F.F., Stuart J.J., Kleinman K., Sumberzul N., Rich-Edwards J.W. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in mongolia. Pediatrics. 2012;130:e561–e567. doi: 10.1542/peds.2011-3029.
    1. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol. 2007;103:793–798. doi: 10.1016/j.jsbmb.2006.12.052.
    1. Gibney K.B., MacGregor L., Leder K., Torresi J., Marshall C., Ebeling P.R., Biggs B.-A. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-saharan Africa. Clin. Infect. Dis. 2008;46:443–446. doi: 10.1086/525268.
    1. Ginde A.A., Mansbach J.M., Camargo C.A., Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch. Intern. Med. 2009;169:384–390. doi: 10.1001/archinternmed.2008.560.
    1. Wayse V., Yousafzai A., Mogale K., Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur. J. Clin. Nutr. 2004;58:563–567. doi: 10.1038/sj.ejcn.1601845.
    1. Aloia J., Li-Ng M. Re: Epidemic influenza and vitamin D. Epidemiol. Infect. 2007;135:1095–1098.
    1. Sabetta J.R., DePetrillo P., Cipriani R.J., Smardin J., Burns L.A., Landry M.L. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5:e11088.
    1. Mitri J., Dawson-Hughes B., Hu F., Pittas A. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 2011;94:486–494. doi: 10.3945/ajcn.111.011684.
    1. Von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient—A randomised, placebo-controlled trial. Br. J. Nutr. 2010;103:549–555. doi: 10.1017/S0007114509992017.
    1. Mitri J., Muraru M.D., Pittas A.G. Vitamin D and type 2 diabetes: A systematic review. Eur. J. Clin. Nutr. 2011;65:1005–1015. doi: 10.1038/ejcn.2011.118.
    1. Forouhi N.G., Ye Z., Rickard A.P., Khaw K.T., Luben R., Langenberg C., Wareham N.J. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173–2182. doi: 10.1007/s00125-012-2544-y.
    1. Afzal S., Bojesen S.E., Nordestgaard B.G. Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and metaanalysis. Clin. Chem. 2013;59:381–391. doi: 10.1373/clinchem.2012.193003.
    1. Gloth F., Alam W., Hollis B. Vitamin D vs. broad spectrum phototherapy in the treatment of seasonal affective disorder. J. Nutr. Health Aginig. 1999;3:5–7.
    1. Jorde R., Sneve M., Figenschau Y., Svartberg J., Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial. J. Intern. Med. 2008;264:599–609. doi: 10.1111/j.1365-2796.2008.02008.x.
    1. Vieth R., Kimball S., Hu A., Walfish P. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr. J. 2004;3:1–10. doi: 10.1186/1475-2891-3-1.
    1. Lansdowne A., Provost S. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology. 1998;135:319–323. doi: 10.1007/s002130050517.
    1. Hujoel P.P. Vitamin D and dental caries in controlled clinical trials: Systematic review and meta-analysis. Nutr. Rev. 2013;71:88–97. doi: 10.1111/j.1753-4887.2012.00544.x.
    1. Dietrich T., Joshipura K.J., Dawson-Hughes B., Bischoff-Ferrari H.A. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am. J. Clin. Nutr. 2004;80:108–113.
    1. Heath K.M., Elovic E.P. Vitamin D deficiency: Implications in the rehabilitation setting. Am. J. Phys. Med. Rehab. 2006;85:916–923. doi: 10.1097/01.phm.0000242622.23195.61.
    1. Schreuder F., Bernsen R.M.D., van der Wouden J.C. Vitamin D supplementation for nonspecific musculoskeletal pain in non-western immigrants: A randomized controlled trial. Ann. Fam. Med. 2012;10:547–555. doi: 10.1370/afm.1402.
    1. Bailey B.A., Manning T., Peiris A.N. Vitamin D Testing Patterns among Six Veterans Medical Centers in the Southeastern United States: Links with Medical Costs. Military Med. 2012;177:70–76. doi: 10.7205/MILMED-D-11-00204.
    1. Peiris A., Bailey B., Manning T. The Relationship of Vitamin D Deficiency to Health Care Costs in Veterans. Military Med. 2008;173:1214–1218.
    1. Genuis S. What’s out there making us sick? J. Environ. Pubic Health. 2012;2012 doi: 10.1155/2012/605137.
    1. Church J., Goodall S., Norman R., Haas M. An economic evaluation of community and residential aged care falls prevention strategies in NSW. NSW Public Health Bull. 2011;22:60–68. doi: 10.1071/NB10051.
    1. Grant W.B., Cross H.S., Garland C.F., Gorham E.D., Moan J., Peterlik M., Porojnicu A.C., Reichrath J., Zittermann A. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog. Biophys. Mol. Biol. 2009;99:104–113. doi: 10.1016/j.pbiomolbio.2009.02.003.
    1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930. doi: 10.1210/jc.2011-0385.
    1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 2012;97:1153–1158. doi: 10.1210/jc.2011-2601.
    1. Pludowski P., Holick M.F., Pilz S., Wagner C.L., Hollis B.W., Grant W.B., Shoenfeld Y., Lerchbaum E., Llewellyn D.J., Kienreich K., Soni M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—A review of recent evidence. Autoimmun. Rev. 2013;12:976–989. doi: 10.1016/j.autrev.2013.02.004.
    1. Souberbielle J.C., Body J.J., Lappe J.M., Plebani M., Shoenfeld Y., Wang T.J., Bischoff-Ferrari H.A., Cavalier E., Ebeling P.R., Fardellone P., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev. 2010;9:709–715. doi: 10.1016/j.autrev.2010.06.009.
    1. Grant W.B., Boucher B.J. Are Hill’s criteria for causality satisfied for vitamin D and periodontal disease. Dermato-Endocrinology. 2010;2:30–36. doi: 10.4161/derm.2.1.12488.
    1. Hossein-nezhad A., Spira A., Holick M.F. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: A randomized double-blind clinical trial. PLoS One. 2013;8:e58725. doi: 10.1371/journal.pone.0058725.
    1. Durup D., Jørgensen H.L., Christensen J., Schwarz P., Heegaard A.M., Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: The CopD study. J. Clin. Endocrinol. Metab. 2012;97:2644–2652. doi: 10.1210/jc.2012-1176.
    1. Sempos C.T., Durazo-Arvizu R.A., Dawson-Hughes B., Yetley E.A., Looker A.C., Schleicher R.L., Cao G., Burt V., Kramer H., Bailey R.L., et al. Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? J. Clin. Endocrinol. Metab. 2013;98:3001–3009. doi: 10.1210/jc.2013-1333.
    1. Rush L., McCartney G., Walsh D., MacKay D. Vitamin D and subsequent all-age and premature mortality: A systematic review. BMC Public Health. 2013;13:679. doi: 10.1186/1471-2458-13-679.
    1. Tomson J., Emberson J., Hill M., Gordon A., Armitage J., Shipley M., Collins R., Clarke R. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur. Heart J. 2013;34:1365–1374. doi: 10.1093/eurheartj/ehs426.
    1. Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: A meta- analysis of prospective cohort studies. Am. J. Clin. Nutr. 2012;95:91–100. doi: 10.3945/ajcn.111.014779.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться